lncRNA FEZF1-AS1对肝癌细胞生物学功能的影响
该研究在肝癌SMMC7721和BEL-7402细胞中通过转染调控lncRNA FEZF1-AS1表达,检测细胞增殖、凋亡、迁移侵袭及黏附分子表达,并用裸鼠移植瘤验证。结果显示lncRNA FEZF1-AS1可促进肝癌细胞生长、迁移和侵袭,抑制凋亡。
要点
- lncRNA FEZF1-AS1在肝癌细胞中下调抑制增殖、促进凋亡,上调则相反。
- lncRNA FEZF1-AS1下调减弱肝癌细胞迁移侵袭及黏附分子表达,上调则增强。
- 裸鼠移植瘤中下调lncRNA FEZF1-AS1显著减小肿瘤体积。
核心结论
- lncRNA FEZF1-AS1可促进肝癌细胞的生长、迁移和侵袭。
研究设计与样本
- 研究在肝癌SMMC7721和BEL-7402细胞中转染sh-FEZF1-AS1和OE-FEZF1-AS1调控lncRNA FEZF1-AS1表达。
主要发现
- 第5天时,sh-FEZF1-AS1转染组SMMC7721和BEL-7402细胞增殖活性分别为(35.43±4.06)%和(34.68±3.97)%,低于sh-NC组(52.21±8.46)%和(53.76±7.64)%,均P<0.05。
- 第5天时,OE-FEZF1-AS1转染组SMMC7721和BEL-7402细胞增殖活性分别为(83.49±6.92)%和(80.31±3.13)%,高于OE-NC组(53.03±8.84)%和(55.11±7.09)%,均P<0.05。
- sh-FEZF1-AS1转染组SMMC7721和BEL-7402细胞凋亡率分别为(13.02±1.38)%和(11.88±1.29)%,高于sh-NC组(5.57±1.46)%和(8.06±1.42)%,均P<0.05。
- OE-FEZF1-AS1转染组SMMC7721和BEL-7402细胞凋亡率分别为(3.01±0.39)%和(3.22±0.43)%,低于OE-NC组(6.68±0.96)%和(6.63±0.45)%,均P<0.05。
- 30天后,sh-FEZF1-AS1组SMMC7721和BEL-7402移植瘤体积分别为(0.26±0.03)cm³和(0.31±0.02)cm³,小于sh-NC组(0.63±0.06)cm³和(0.72±0.08)cm³,均P<0.05。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect of long-chain non-coding RNA Fez family zinc finger protein 1 antisense RNA1 (lncRNA FEZF1-AS1) on the biological function of hepatocellular carcinoma (HCC). Methods: SMMC771 and BEL-7402 cells were transfected with sh-FEZF1-AS1 and OE-FEZF1-AS1, respectively. The expression of lncRNA FEZF1-AS1 was detected by real-time quantitative PCR. Cell proliferation was detected by Cell Counting Kit-8 (CCK-8), and apoptosis was detected by flow cytometry. The effects of lncRNA FEZF1-AS1 on invasion and migration were detected by Transwell and wound healing assays. The expression levels of adhesion molecules were detected by Western blot. The effect of lncRNA FEZF1-AS1 on the in vivo growth was verified by nude mice xenograft experiments. Results: The silencing or ectopic expression of lncRNA FEZF1-AS1 inhibited or promoted the proliferation of hepatocellular carcinoma cells. CCK-8 assay showed that the proliferation abilities of SMMC7721 and BEL-7402 cells in sh-FEZF1-AS1 transfection group significantly decreased, achieving (35.43±4.06)% and (34.68±3.97)%, respectively, on the fifth day. There were significant differences between sh-FEZF1-AS1 group and sh-NC group [52.21±8.46)% and (53.76±7.64)%] (all P<0.05). In contrast, the proliferation ability of SMMC7721 and BEL-7402 cells transfected with OE-FEZF1-AS1 was significantly increased, achieving (83.49±6.92)% and (80.31±3.13)%, respectively, on the fifth day. There were significant differences between OE-FEZF1-AS1 and OE-NC group [53.03±8.84)% and (55.11±7.09)%] (all P<0.05). The subsequent flow cytometry results showed that cell apoptotic rates of SMMC7721 and BEL-7402 cells transfected with sh-FEZF1-AS1 were (13.02±1.38)% and (11.88±1.29)%, respectively, which were significantly higher than those in sh-NC groups [(5.57±1.46)% and (8.06±1.42)%, respectively, all P<0.05]. In contrast, the apoptotic rates of SMMC7721 and BEL-7402 cells transfected with OE-FEZF1-AS1 were (3.01±0.39)% and (3.22±0.43)%, which were significantly lower than those in OE-NC groups [(6.68±0.96)% and (6.63±0.45)%, all P<0.05]. In addition, knockdown or overexpression of lncRNA FEZF1-AS1 expression inhibited or enhanced the migration and invasion abilities as well as the levels of adhesion molecules in hepatocellular carcinoma cells. After 30 days of feeding under the same conditions, the tumor volumes of sh-FEZF1-AS1 and sh-NC SMMC7721 cells xenograft mice models were (0.26±0.03) cm(3) and (0.63±0.06) cm(3), respectively, showing significant difference (P<0.05). The tumor volumes of sh-FEZF1-AS1 and sh-NC BEL-7402 cells were (0.31±0.02) cm(3) and (0.72±0.08) cm(3), and the difference was statistically significant (P<0.05). Conclusion: lncRNA FEZF1-AS1 may strengthen the growth, migration and invasion of hepatocellular carcinoma cells. 目的: 探讨长链非编码RNA Fez家族锌指蛋白1反义RNA1(lncRNA FEZF1-AS1)的表达对肝癌细胞生物学功能的影响。 方法: 以sh-FEZF1-AS1和OE-FEZF1-AS1转染肝癌SMMC771和BEL-7402细胞,采用实时荧光定量PCR法检测下调或上调lncRNA FEZF1-AS1后肝癌细胞中lncRNA FEZF1-AS1的表达变化。以细胞计数盒8(CCK-8)法检测细胞增殖,流式细胞术检测细胞凋亡。采用Transwell法和划痕实验检测lncRNA FEZF1-AS1对肝癌细胞侵袭和迁移能力的影响,采用Western blot法检测肝癌细胞内黏附分子的表达水平。裸鼠移植瘤实验验证lncRNA FEZF1-AS1对肝癌生长的影响。 结果: lncRNA FEZF1-AS1在肝癌细胞中的下调或上调表达能够抑制或促进肝癌细胞的增殖。CCK-8法检测结果显示,sh-FEZF1-AS1转染组SMMC7721和BEL-7402细胞的增殖能力明显减弱。第5天时,SMMC7721和BEL-7402细胞的增殖活性分别为(35.43±4.06)%和(34.68±3.97)%,与sh-NC组[分别为(52.21±8.46)%和(53.76±7.64)%]比较,差异均有统计学意义(均P<0.05)。OE-FEZF1-AS1转染组SMMC7721和BEL-7402细胞的增殖能力明显升高。第5天时,SMMC7721和BEL-7402细胞的增殖活性分别为(83.49±6.92)%和(80.31±3.13)%,与OE-NC组[分别为(53.03±8.84)%和(55.11±7.09)%]比较,差异均有统计学意义(均P<0.05)。流式细胞术检测结果显示,sh-FEZF1-AS1转染组SMMC7721细胞的凋亡率为(13.02±1.38)%,明显高于sh-NC组[(5.57±1.46)%, P<0.05]。sh-FEZF1-AS1转染组BEL-7402细胞的凋亡率为(11.88±1.29)%,明显高于sh-NC组[(8.06±1.42)%,P<0.05]。OE-FEZF1-AS1转染组SMMC7721细胞的凋亡率为(3.01±0.39)%,明显低于OE-NC组[(6.68±0.96)%,P<0.05]。OE-FEZF1-AS1转染组BEL-7402细胞的凋亡率为(3.22±0.43)%,明显低于OE-NC组(6.63±0.45)%,P<0.05]。在肝癌细胞内下调或上调lncRNA FEZF1-AS1的表达能够减弱或增强肝癌细胞的迁移和侵袭能力。抑制或增强lncRNA FEZF1-AS1的表达水平可抑制或增强肝癌细胞中黏附分子的表达。经过30 d同等条件喂养后,对切除的裸鼠移植瘤进行测量,sh-FEZF1-AS1组和sh-NC组SMMC7721细胞移植瘤的肿瘤体积分别为(0.26±0.03)cm(3)和(0.63±0.06)cm(3),差异有统计学意义(P<0.05);sh-FEZF1-AS1组和sh-NC组BEL-7402细胞移植瘤的肿瘤体积分别为(0.31±0.02)cm(3)和(0.72±0.08)cm(3),差异有统计学意义(P<0.05)。 结论: lncRNA FEZF1-AS1可促进肝癌细胞的生长、迁移和侵袭。.
引用
- Yao J, Wang XP, Zhang ZZ, et al. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31550856. doi:10.3760/cma.j.issn.0253-3766.2019.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。